Gossamer Bio, Inc. announced it has regained compliance with the Nasdaq's minimum bid price requirement, resolving a potential delisting issue. The company received a notification from Nasdaq on September 25, 2026, confirming that the matter is now closed.
Key Details
- Compliance Regained: Nasdaq confirmed the company is in compliance with the minimum bid price of $1.00 per share as required by Listing Rule 5450(a)(1).
- Corrective Action: Compliance was achieved after the company executed a 1-for-80 reverse stock split, which became effective on September 10, 2026.
- Timeline: The company was initially notified of non-compliance on April 8, 2026, after its common stock traded below $1.00 for 30 consecutive business days.